House Bill 7630
117th Congress(2021-2022)
Childhood Cancer STAR Reauthorization Act of 2022
Introduced
Introduced in House on Apr 28, 2022
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
7630
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act
This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
April 28, 2022
Sort by most recent
04/29/2022
Referred to the Subcommittee on Health.
04/28/2022
Referred to the House Committee on Energy and Commerce.
04/28/2022
Introduced in House
Public Record
Record Updated
Mar 8, 2023 7:58:48 PM